A comparison of long-term survivors and short-term survivors with glioblastoma, subventricular zone involvement: a predictive factor for survival?

Radiation Oncology - Tập 9 Số 1 - 2014
Sebastian Adeberg1, Tilman Bostel1, Laila König1, Thomas Welzel1, Jürgen Debus2, Stephanie E. Combs2
1Department of Radiation Oncology, University Hospital of Heidelbergy, Heidelberg, Im Neuenheimer Feld 400, 69120, Germany
2Heidelberg Ion Therapy Center (HIT), Heidelberg, Im Neuenheimer Feld 450, 69120, Germany

Tóm tắt

Từ khóa


Tài liệu tham khảo

Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K: Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009,10(5):459-466. 10.1016/S1470-2045(09)70025-7

Forsyth PA, Cairncross JG: Treatment of malignant glioma in adults. Curr Opin Neurol 1995,8(6):414-418. 10.1097/00019052-199512000-00002

Scott JN, Rewcastle NB, Brasher PM, Fulton D, MacKinnon JA, Hamilton M, Cairncross JG, Forsyth P: Which glioblastoma multiforme patient will become a long-term survivor? A population-based study. Ann Neurol 1999,46(2):183-188. 10.1002/1531-8249(199908)46:2<183::AID-ANA7>3.0.CO;2-7

Smoll NR, Schaller K, Gautschi OP: Long-term survival of patients with glioblastoma multiforme (GBM). J Clin Neurosci 2013,20(5):670-675. 10.1016/j.jocn.2012.05.040

Laws ER, Parney IF, Huang W, Anderson F, Morris AM, Asher A, Lillehei KO, Bernstein M, Brem H, Sloan A: Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg 2003,99(3):467-473. 10.3171/jns.2003.99.3.0467

Lamborn KR, Chang SM, Prados MD: Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. Neuro Oncol 2004,6(3):227-235. 10.1215/S1152851703000620

Chaichana KL, Pendleton C, Chambless L, Camara-Quintana J, Nathan JK, Hassam-Malani L, Li G, Harsh GR, Thompson RC, Lim M: Multi-institutional validation of a preoperative scoring system which predicts survival for patients with glioblastoma. J Clin Neurosci 2013,20(10):1422-6. 10.1016/j.jocn.2013.02.007

Hegi ME, Liu L, Herman JG, Stupp R, Wick W, Weller M, Mehta MP, Gilbert MR: Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity. J Clin Oncol 2008,26(25):4189-4199. 10.1200/JCO.2007.11.5964

Martinez R, Schackert G, Yaya-Tur R, Rojas-Marcos I, Herman JG, Esteller M: Frequent hypermethylation of the DNA repair gene MGMT in long-term survivors of glioblastoma multiforme. J Neurooncol 2007,83(1):91-93. 10.1007/s11060-006-9292-0

Lim DA, Cha S, Mayo MC, Chen MH, Keles E, VandenBerg S, Berger MS: Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype. Neuro Oncol 2007,9(4):424-429. 10.1215/15228517-2007-023

Jafri NF, Clarke JL, Weinberg V, Barani IJ, Cha S: Relationship of glioblastoma multiforme to the subventricular zone is associated with survival. Neuro Oncol 2013,15(1):91-96. 10.1093/neuonc/nos268

Krex D, Klink B, Hartmann C, von Deimling A, Pietsch T, Simon M, Sabel M, Steinbach JP, Heese O, Reifenberger G: Long-term survival with glioblastoma multiforme. Brain 2007,130(Pt 10):2596-2606.

Hartmann C, Hentschel B, Simon M, Westphal M, Schackert G, Tonn JC, Loeffler M, Reifenberger G, Pietsch T, von Deimling A: Long-term survival in primary glioblastoma with versus without isocitrate dehydrogenase mutations. Clin Cancer Res 2013,19(18):5146-57. 10.1158/1078-0432.CCR-13-0017

Sonoda Y, Kumabe T, Watanabe M, Nakazato Y, Inoue T, Kanamori M, Tominaga T: Long-term survivors of glioblastoma: clinical features and molecular analysis. Acta Neurochir (Wien) 2009,151(11):1349-1358. 10.1007/s00701-009-0387-1

Scheithauer BW, Fuller GN, VandenBerg SR: The 2007 WHO classification of tumors of the nervous system: controversies in surgical neuropathology. Brain Pathol 2008,18(3):307-316. 10.1111/j.1750-3639.2008.00179.x

Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005,352(10):987-996. 10.1056/NEJMoa043330

Devaux BC, O'Fallon JR, Kelly PJ: Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome. J Neurosurg 1993,78(5):767-775. 10.3171/jns.1993.78.5.0767

Wang X, Liu YH, Xie F, You C, Mao Q: [A clinical and molecular study of long-term survival glioblastomas]. Zhonghua Wai Ke Za Zhi 2013,51(2):166-170.

Ohgaki H, Kleihues P: Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 2005,64(6):479-489.

Parsa AT, Wachhorst S, Lamborn KR, Prados MD, McDermott MW, Berger MS, Chang SM: Prognostic significance of intracranial dissemination of glioblastoma multiforme in adults. J Neurosurg 2005,102(4):622-628. 10.3171/jns.2005.102.4.0622

Aguirre A, Gallo V: Postnatal neurogenesis and gliogenesis in the olfactory bulb from NG2-expressing progenitors of the subventricular zone. J Neurosci 2004,24(46):10530-10541. 10.1523/JNEUROSCI.3572-04.2004

Chaichana KL, McGirt MJ, Frazier J, Attenello F, Guerrero-Cazares H, Quinones-Hinojosa A: Relationship of glioblastoma multiforme to the lateral ventricles predicts survival following tumor resection. J Neurooncol 2008,89(2):219-224. 10.1007/s11060-008-9609-2

Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ, Group AL-GS: Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 2006,7(5):392-401. 10.1016/S1470-2045(06)70665-9